CareNet, Inc.
CareNet, Inc. (2150.T) Stock Competitors & Peer Comparison
See (2150.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2150.T | ¥740.00 | +3.06% | 31.7B | 25.75 | ¥28.74 | +1.62% |
| 2413.T | ¥1,894.00 | +1.83% | 1.3T | 31.82 | ¥59.52 | +1.11% |
| 4483.T | ¥3,944.00 | +2.98% | 257.9B | 44.77 | ¥88.09 | +0.41% |
| 2175.T | ¥1,508.50 | +2.58% | 128.2B | 21.28 | ¥70.88 | +1.89% |
| 4480.T | ¥3,090.00 | -0.64% | 99.3B | 44.76 | ¥69.04 | N/A |
| 3733.T | ¥13,490.00 | -0.07% | 70.6B | 15.02 | ¥898.43 | +0.96% |
| 9438.T | ¥928.00 | +0.54% | 51.4B | 19.99 | ¥46.43 | +1.83% |
| 4820.T | ¥727.00 | +0.83% | 50.3B | 16.99 | ¥42.79 | +5.91% |
| 6078.T | ¥1,713.00 | +1.30% | 45.7B | 57.89 | ¥29.59 | +1.52% |
| 5592.T | ¥3,190.00 | +0.79% | 35.8B | 17.65 | ¥180.72 | +0.85% |
Stock Comparison
2150.T vs 2413.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 2413.T has a market cap of 1.3T. Regarding current trading prices, 2150.T is priced at ¥740.00, while 2413.T trades at ¥1,894.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 2413.T's P/E ratio is 31.82. In terms of profitability, 2150.T's ROE is +0.11%, compared to 2413.T's ROE of +0.11%. Regarding short-term risk, 2150.T is more volatile compared to 2413.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 2413.T's competition here
2150.T vs 4483.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 4483.T has a market cap of 257.9B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 4483.T trades at ¥3,944.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 4483.T's P/E ratio is 44.77. In terms of profitability, 2150.T's ROE is +0.11%, compared to 4483.T's ROE of +0.10%. Regarding short-term risk, 2150.T is less volatile compared to 4483.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2150.T.Check 4483.T's competition here
2150.T vs 2175.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 2175.T has a market cap of 128.2B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 2175.T trades at ¥1,508.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 2175.T's P/E ratio is 21.28. In terms of profitability, 2150.T's ROE is +0.11%, compared to 2175.T's ROE of +0.13%. Regarding short-term risk, 2150.T is less volatile compared to 2175.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2150.T.Check 2175.T's competition here
2150.T vs 4480.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 4480.T has a market cap of 99.3B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 4480.T trades at ¥3,090.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 4480.T's P/E ratio is 44.76. In terms of profitability, 2150.T's ROE is +0.11%, compared to 4480.T's ROE of +0.12%. Regarding short-term risk, 2150.T is more volatile compared to 4480.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 4480.T's competition here
2150.T vs 3733.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 3733.T has a market cap of 70.6B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 3733.T trades at ¥13,490.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 3733.T's P/E ratio is 15.02. In terms of profitability, 2150.T's ROE is +0.11%, compared to 3733.T's ROE of +0.14%. Regarding short-term risk, 2150.T is more volatile compared to 3733.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 3733.T's competition here
2150.T vs 9438.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 9438.T has a market cap of 51.4B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 9438.T trades at ¥928.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 9438.T's P/E ratio is 19.99. In terms of profitability, 2150.T's ROE is +0.11%, compared to 9438.T's ROE of +0.16%. Regarding short-term risk, 2150.T is more volatile compared to 9438.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 9438.T's competition here
2150.T vs 4820.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 4820.T has a market cap of 50.3B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 4820.T trades at ¥727.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 4820.T's P/E ratio is 16.99. In terms of profitability, 2150.T's ROE is +0.11%, compared to 4820.T's ROE of +0.10%. Regarding short-term risk, 2150.T is more volatile compared to 4820.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 4820.T's competition here
2150.T vs 6078.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 6078.T has a market cap of 45.7B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 6078.T trades at ¥1,713.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 6078.T's P/E ratio is 57.89. In terms of profitability, 2150.T's ROE is +0.11%, compared to 6078.T's ROE of +0.12%. Regarding short-term risk, 2150.T is more volatile compared to 6078.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 6078.T's competition here
2150.T vs 5592.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 5592.T has a market cap of 35.8B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 5592.T trades at ¥3,190.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 5592.T's P/E ratio is 17.65. In terms of profitability, 2150.T's ROE is +0.11%, compared to 5592.T's ROE of +0.27%. Regarding short-term risk, 2150.T is more volatile compared to 5592.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 5592.T's competition here
2150.T vs 3939.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 3939.T has a market cap of 20.9B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 3939.T trades at ¥440.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 3939.T's P/E ratio is 21.30. In terms of profitability, 2150.T's ROE is +0.11%, compared to 3939.T's ROE of +0.26%. Regarding short-term risk, 2150.T is more volatile compared to 3939.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 3939.T's competition here
2150.T vs 3902.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 3902.T has a market cap of 19.6B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 3902.T trades at ¥517.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 3902.T's P/E ratio is -24.92. In terms of profitability, 2150.T's ROE is +0.11%, compared to 3902.T's ROE of -0.22%. Regarding short-term risk, 2150.T is less volatile compared to 3902.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2150.T.Check 3902.T's competition here
2150.T vs 3649.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 3649.T has a market cap of 19.1B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 3649.T trades at ¥746.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 3649.T's P/E ratio is 16.46. In terms of profitability, 2150.T's ROE is +0.11%, compared to 3649.T's ROE of +0.20%. Regarding short-term risk, 2150.T is more volatile compared to 3649.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 3649.T's competition here
2150.T vs 6095.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 6095.T has a market cap of 16.6B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 6095.T trades at ¥762.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 6095.T's P/E ratio is 9.68. In terms of profitability, 2150.T's ROE is +0.11%, compared to 6095.T's ROE of +0.18%. Regarding short-term risk, 2150.T is more volatile compared to 6095.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 6095.T's competition here
2150.T vs 5585.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 5585.T has a market cap of 15.8B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 5585.T trades at ¥2,184.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 5585.T's P/E ratio is 58.47. In terms of profitability, 2150.T's ROE is +0.11%, compared to 5585.T's ROE of +0.11%. Regarding short-term risk, 2150.T is more volatile compared to 5585.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 5585.T's competition here
2150.T vs 4263.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 4263.T has a market cap of 14.4B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 4263.T trades at ¥855.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 4263.T's P/E ratio is -24.75. In terms of profitability, 2150.T's ROE is +0.11%, compared to 4263.T's ROE of -0.06%. Regarding short-term risk, 2150.T is less volatile compared to 4263.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2150.T.Check 4263.T's competition here
2150.T vs 9341.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 9341.T has a market cap of 12.3B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 9341.T trades at ¥711.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 9341.T's P/E ratio is 8.99. In terms of profitability, 2150.T's ROE is +0.11%, compared to 9341.T's ROE of +0.20%. Regarding short-term risk, 2150.T is more volatile compared to 9341.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 9341.T's competition here
2150.T vs 4320.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 4320.T has a market cap of 11.5B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 4320.T trades at ¥699.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 4320.T's P/E ratio is 23.36. In terms of profitability, 2150.T's ROE is +0.11%, compared to 4320.T's ROE of +0.07%. Regarding short-term risk, 2150.T is more volatile compared to 4320.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 4320.T's competition here
2150.T vs 2934.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 2934.T has a market cap of 8.1B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 2934.T trades at ¥1,550.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 2934.T's P/E ratio is 89.96. In terms of profitability, 2150.T's ROE is +0.11%, compared to 2934.T's ROE of -1.32%. Regarding short-term risk, 2150.T is more volatile compared to 2934.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 2934.T's competition here
2150.T vs 3628.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 3628.T has a market cap of 7.6B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 3628.T trades at ¥598.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 3628.T's P/E ratio is -2.32. In terms of profitability, 2150.T's ROE is +0.11%, compared to 3628.T's ROE of -1.24%. Regarding short-term risk, 2150.T is more volatile compared to 3628.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 3628.T's competition here
2150.T vs 3671.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 3671.T has a market cap of 7.6B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 3671.T trades at ¥314.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 3671.T's P/E ratio is 15.70. In terms of profitability, 2150.T's ROE is +0.11%, compared to 3671.T's ROE of +0.19%. Regarding short-term risk, 2150.T is more volatile compared to 3671.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 3671.T's competition here
2150.T vs 9218.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 9218.T has a market cap of 7B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 9218.T trades at ¥678.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 9218.T's P/E ratio is -229.83. In terms of profitability, 2150.T's ROE is +0.11%, compared to 9218.T's ROE of +0.26%. Regarding short-term risk, 2150.T is more volatile compared to 9218.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 9218.T's competition here
2150.T vs 4172.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 4172.T has a market cap of 5B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 4172.T trades at ¥2,265.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 4172.T's P/E ratio is 12.21. In terms of profitability, 2150.T's ROE is +0.11%, compared to 4172.T's ROE of +0.10%. Regarding short-term risk, 2150.T is more volatile compared to 4172.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 4172.T's competition here
2150.T vs 6034.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 6034.T has a market cap of 4B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 6034.T trades at ¥700.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 6034.T's P/E ratio is -12.38. In terms of profitability, 2150.T's ROE is +0.11%, compared to 6034.T's ROE of -0.08%. Regarding short-term risk, 2150.T is more volatile compared to 6034.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 6034.T's competition here
2150.T vs 6545.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 6545.T has a market cap of 3.7B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 6545.T trades at ¥685.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 6545.T's P/E ratio is 14.69. In terms of profitability, 2150.T's ROE is +0.11%, compared to 6545.T's ROE of +0.17%. Regarding short-term risk, 2150.T is more volatile compared to 6545.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 6545.T's competition here
2150.T vs 4438.T Comparison July 2025
2150.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2150.T stands at 31.7B. In comparison, 4438.T has a market cap of 3B. Regarding current trading prices, 2150.T is priced at ¥740.00, while 4438.T trades at ¥361.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2150.T currently has a P/E ratio of 25.75, whereas 4438.T's P/E ratio is -3.66. In terms of profitability, 2150.T's ROE is +0.11%, compared to 4438.T's ROE of -0.88%. Regarding short-term risk, 2150.T is more volatile compared to 4438.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2150.T.Check 4438.T's competition here